CALGB 90601 (Alliance): Randomized, double blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma
- Citation:
- J Clin Oncol vol 37 (15 suppl) abst 4503
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 3485
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180853, U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Jonathan Rosenberg Karla Ballman Susan Halabi Colleen Watt Olwen Mary Hahn Preston D. Steen Hahn Olwen Dreicer Robert Thomas Flaig Walter Stadler Christopher Sweeney Amir Mortazavi Michael Morris
- Networks:
- LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-NY016, LAPS-OH007, SANFORD, VA002
- Study
- CALGB-90601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: